Open Orphan PLC (LON:ORPH) has announced the launch of hVIVO's COVID Clear Test, its antibody testing service, following the successful completion of installation, testing and training for the coronavirus (COVID-19) test,
The service will be offered to large employer groups and partners including GP networks, nursing care businesses, health clinics and private hospitals.
Samples will be tested in the company's London lab with results returned within 48 hours.
Open Orphan subsidiary hVIVO is using the Quotient MosaiQ system and MosaiQ COVID-19 Antibody Microarray, which it said has the “best-in-class COVID-19 antibody testing performance”.
In a statement, Open Orpan chairman Cathal Friel said: "hVIVO is a world-class company with best in class scientists and facilities. We are very excited to be offering this service and I am confident our work will help large companies and clinics in the UK test their staff and patients to ensure the safety of all employees.”